Hormone Therapy and Risk of Co-morbidities22
| No HT | HT | |
|---|---|---|
| Risk of MI | 2/1000 | 3 to 7/1000 (after 1 year of HT use) |
| Risk of VTE | 2/1000 | 4 to 11/1000 (after 1 year of use) |
| Risk of CVA | 6/1000 | 6 to 12/1000 (after 3 years of use) |
| Risk of breast cancer | 19/1000 | 20 to 30/1000 (after 5.6 years of use) |
*Based on data from 43,637 post-menopausal American women.
**Data may vary based on type of formulation and mode of delivery of HT.
Abbreviations: VTE, Venous Thromboembolism; MI, Myocardial Infarction; CVA, Cerebrovascular Accident